Disease: Rubella virus antenatal infection
- A comparison of three tests for rubella antibody screening
- A prospective study of primary cytomegalovirus infection in pregnant women
- Antenatal rubella serosurvey in Maputo, Mozambique
- Antenatal screening and prevalence of infection: surveillance in London, 2000-2007
- Antenatal screening for hepatitis B and antibodies to Toxoplasma gondii and rubella virus: evaluation of two commercial immunoassay systems
- Antenatal screening for Toxoplasma gondii, Cytomegalovirus, rubella and Treponema pallidum infections in northern Benin
- Antenatal screening practice for infectious diseases by general practitioners in Australia
- Arguments for an infectious cause of IUGR
- Attitude towards serological tests for infection during pregnancy
- Beyond TORCH: A narrative review of the impact of antenatal and perinatal infections on the risk of disability
- Case report on early treatment with valaciclovir after maternal primary cytomegalovirus infection
- Clinical utility of maternal TORCH screening in fetal growth restriction: A retrospective two-centre study
- Community prevalence of antibodies to human immunodeficiency virus in rural and urban Vellore, Tamil Nadu
- Comparison of immulite with vidas for detection of infection in a low-prevalence population of pregnant women in The Netherlands
- Congenital lymphocytic choriomeningitis virus: when to consider the diagnosis
- Congenital rubella and cytomegalovirus infections in and around Chandigarh
- Diagnosis of congenital infection
- Effect of selective vaccination on rubella susceptibility and infection in pregnancy
- Epidemiological changes in rubella IgG antibody levels detected in antenatal women from a retrospective rubella seroprevalence study
- Epidemiological Evaluation of Rubella Virus Infection among Pregnant Women in Ibadan, Nigeria
- Estimating the burden of rubella virus infection and congenital rubella syndrome through a rubella immunity assessment among pregnant women in the Democratic Republic of the Congo: Potential impact on vaccination policy
- Evaluation of fully automated assays for the detection of Rubella IgM and IgG antibodies by the Elecsys() immunoassay system
- Evaluation of fully automated assays for the detection of Rubella IgM and IgG antibodies by the Elecsys(®) immunoassay system
- Evaluation of three immunoassays used for detection of anti-rubella virus immunoglobulin M antibodies
- Factors associated with low immunity to rubella infection on antenatal screening
- Factors Associated with the Uptake of Antenatal Tetanus Toxoids Containing Vaccine by First-Time Mothers in Nigeria: Findings from the 2018 Nigerian Demographic Health Survey
- Fetal and neonatal abnormalities due to congenital rubella syndrome: a review of literature
- Hepatitis B virus infection in Northern Ireland 1970-1987
- Impact of the two-dose rubella vaccination regimen on incidence of rubella seronegativity in gravidae aged 25 years and younger
- Infection of the fetus and the newborn: prevention, treatment and related handicap
- Infectious immune status in an obstetric population of Pakistani immigrants in Norway
- Is post partum rubella vaccination worthwhile?
- Laboratory diagnosis of intrauterine and perinatal virus infections
- Line Immunoassay: A Rapid Test for Screening TORCH Complex in Antenatal Patients with Bad Obstetric History
- Maternal infections
- Maternal virus infections in pregnancy and type 1 diabetes in their offspring: Systematic review and meta-analysis of observational studies
- Modelling the incidence of congenital rubella syndrome in developing countries
- Non-malarial infectious diseases of antenatal care in pregnant women in Franceville, Gabon
- Pattern of Cerebral Palsy Among Sudanese Children Less Than 15 Years of Age
- Performance of the Elecsys Rubella IgG assay in the diagnostic laboratory setting for assessment of immune status
- Pregnant women in and around dhaka city: are their children at risk of developing congenital rubella syndrome?
- Prevalence of infections affecting the child among pregnant women in Yaounde, Cameroon
- Prevalence of rubella and cytomegalovirus antibodies among pregnant women in northern Turkey
- Prevalence of Rubella Antibodies among Fertile Women in the West of Romania, 18 Years after the Implementation of Immunization
- Prevalence of rubella antibody in pregnant women in Ibadan, Nigeria
- Prevalence of rubella-specific IgG antibody in non-immunized pregnant women in Maiduguri, north eastern Nigeria
- Prevalence of Serum Antibodies to TORCH Infection in and Around Varanasi, Northern India
- Prior pregnancy and antenatal rubella sero-negativity-evidence of persistent maternal immunologic alteration?
- Rubella antibodies in normal pregnant women at Srinagarind Hospital, Khon Kaen, Thailand
- Rubella antibody status of patients attending a south-west London antenatal clinic, 2007-2012
- Rubella in the Russian Federation: epidemiological features and control measures to prevent the congenital rubella syndrome
- Rubella infection in pregnancy in naturally acquired immunity
- Rubella seronegativity in antenatal screening - Is it influenced by the introduction of universal childhood rubella immunization?
- Rubella Seroprevalence and real-time PCR detection of RUBV among Congolese pregnant women
- Rubella susceptibility in Jamaican women, 1996
- Rubella vaccination and congenital rubella syndrome in Western Australia
- Rubella virus IgM and IgG antibodies with avidity in pregnant women and outcomes at a tertiary facility in Ghana
- Rubella virus infection and associated factors among pregnant women attending the antenatal care clinics of public hospitals in Hawassa City, Southern Ethiopia: a cross-sectional study
- Rubella virus, <em>Toxoplasma gondii</em> and <em>Treponema pallidum</em> congenital infections among full term delivered women in an urban area of Tanzania: a call for improved antenatal care
- Rubella virus, Toxoplasma gondii and Treponema pallidum congenital infections among full term delivered women in an urban area of Tanzania: a call for improved antenatal care
- Screening cytomegalovirus, rubella and toxoplasma infections in pregnant women with unknown pre-pregnancy serological status
- Screening for TORCH Antibodies in Croatian Childbearing-Aged Women, 2014-2023
- Screening for TORCH infections in pregnant women: a report from Delhi
- Sero-positivity rate of rubella and associated factors among pregnant women attending antenatal care in Mwanza, Tanzania
- Sero-prevalence of rubella among pregnant women in India, 2017
- Serologic survey of specific rubella virus IgM in the sera of pregnant women in Makurdi, Benue State, Nigeria
- Seroprevalence and Determinants of ToRCH Pathogens in Pregnant Women in the Sub-Himalayan Region
- Seroprevalence and risk factors for rubella infection in pregnant women attending a tertiary hospital in Kano-Nigeria
- Seroprevalence of rubella among pregnant women in Khartoum state, Sudan
- Seroprevalence of rubella antibodies among antenatal patients in the Western Cape
- Seroprevalence of rubella antibodies among pregnant females in Sri Lanka
- Seroprevalence of rubella IgG antibody in pregnant women in osogbo, Nigeria
- Seroprevalence of rubella in pregnant women in Kashmir
- Seroprevalence of rubella virus among pregnant women: A 4-year registered-based study from family medicine and obstetric clinics in Saudi Arabia
- Seroprevalence of rubella virus antibodies among pregnant women in the Center and South-West regions of Cameroon
- Seroprevalence of rubella virus infection among antenatal care clients of Halaba Town public health facilities, southern Ethiopia
- Seroprevalence of rubella-specific IgM and IgG antibodies among pregnant women seen in a tertiary hospital in Nigeria
- Seroprevalence of torch infection in bad obstetric history
- Seroprevalence of TORCH infections in antenatal and HIV positive patient populations
- Seroprevalence of Toxoplasma gondii, cytomegalovirus, rubella virus and Chlamydia trachomatis among infertile women attending in vitro fertilization center, Gaza strip, Palestine
- Seroprevalence of Toxoplasma gondii, rubella and cytomegalovirus among pregnant women in southern Turkey
- Seroprevalence of Toxoplasma gondii, rubella and cytomegalovirus among pregnant women in western region of Turkey
- Serum levels of rubella-specific antibodies in Swedish women following three decades of vaccination programmes
- Significance of IgG-Avidity in Antenatal Rubella Diagnosis
- Simultaneous Seroprevalence to <em>Toxoplasma gondii</em>, Cytomegalovirus and Rubella Virus in Childbearing Women from Western Romania
- Simultaneous Seroprevalence to Toxoplasma gondii, Cytomegalovirus and Rubella Virus in Childbearing Women from Western Romania
- Single-radial-hemolysis test for the assay of rubella antibody in antenatal, vaccinated, and rubella virus-infected patients
- Small head circumference at birth: an 8-year retrospective cohort study in China
- Survey of human immunodeficiency virus infection among pregnant women in England and Wales: 1990-93
- Susceptibility to cytomegalovirus, parvovirus B19 and age-dependent differences in levels of rubella antibodies among pregnant women
- The development of an M antibody capture ELISA for rubella IgM
- The impact of a rubella prevention policy on the outcome of rubella in pregnancy
- The risk factors of exposure to rubella among pregnant women in Zaria 2013
- The role of infection in miscarriage
- The status of rubella IgG antibody titer between antenatal and postnatal among pregnant non-immune to rubella
- TORCH (Toxoplasmosis, Other, Rubella, Cytomegalovirus, Herpes Simplex Virus) Infection and the Enigma of Anomalous Fetal Development: Pregnancy Puzzles
- TORCH Antibodies Among Pregnant Women and Their Newborns Receiving Care at Kilimanjaro Christian Medical Centre, Moshi, Tanzania
- TORCH infections
- Vertical Transplacental Infections
- Viral infections in pregnancy: advice for healthcare workers